Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
absorption, Brownian, Carlo, choose, document, embedded, engineering, foreign, forfeited, formatted, grew, Inline, Instance, Inventive, July, Label, lattice, lead, leadership, Linkbase, Monte, notice, occur, occurred, Page, pharmacy, precipitated, professional, recover, requisite, rollout, Schema, Sequential, specialty, Taxonomy, tracking, underlying, unfavorable, unvested, voluntary, XBRL
Filing tables
Filing exhibits
- 10-Q Quarterly report
- 10 Summary of Non-employee Director Compensation
- 10 Repro Med Systems, Inc. 2021 Omnibus Equity Incentive Plan
- 10 Form of Non-qualified/incentive Stock Option Award Agreement
- 10 Form of Indemnification Agmt. Directors & Executive Officers
- 31 Certification of Principal Executive Officer
- 31 Certification of Principal Financial Officer
- 32 Certification of Principal Executive Officer
- 32 Certification of Principal Financial Officer
- Download Excel data file
- View Excel data file
Associated KRMD transcripts
KRMD similar filings
Filing view
External links
EXHIBIT 32.1
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350
AS ADDED BY SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Repro Med Systems, Inc. (the “Company”) on Form 10-Q (the “Report”) for the quarter ended June 30, 2021 as filed with the Securities and Exchange Commission, I, Linda Tharby, Principal Executive Officer, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
(1) | the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and | |
(2) | the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
Date: August 11, 2021
/s/ Linda Tharby
Linda Tharby
President and Chief Executive Officer